Peter Haggie, PhD, is an associate professor at the University of California, San Francisco. His research focuses on the identification of drug-like small molecules that can be used to develop novel CF-relevant therapeutic approaches. Ongoing projects in his lab are developing modulators for rare CFTR mutations and mutation-agnostic approaches for pulmonary and non-pulmonary CF indications. In addition to his research, Dr. Haggie is the Scientific Director of Emily's Entourage, a non-profit dedicated to the development of therapies for CF subjects with the W1282X-CFTR and other rare mutations.